Deep Tech Startups

Spaya is an AI-powered retrosynthesis platform that identifies synthetic routes to target compounds by converting them into commercially available starting materials. It serves chemists and drug discovery teams seeking to accelerate research through rapid, customizable synthesis planning.

1 investor

iLabService provides infrastructure for regulated laboratories to capture, govern, and audit physical evidence from lab operations. The platform integrates environment monitoring, equipment utilization, inventory, samples, compliance, and audit trails into a single system serving labs requiring regulated operations and compliance management.

1 investor

illumiSonics develops MLI™, a proprietary molecular imaging platform that extracts diagnostic information from unstained tissue samples for use in pathology, surgical imaging, and ophthalmology. The technology enables virtual histology and AI-powered diagnostics without destructive sample consumption, targeting pharmaceutical companies, clinical labs, and surgical centers.

1 investor

ILLUTHERM develops LED-based heating systems that rapidly heat industrial materials like steel, ceramics, and cement to over 1000°C using blue light technology. The company targets manufacturing and industrial processes seeking to reduce CO2 emissions and transition from fossil fuel-based heating to electrified, energy-efficient solutions.

1 investor

ImageCyte develops precision nanowell plate technology that prepares cells, organoids, and model organisms for imaging, aiming to improve imaging quality, reproducibility, and throughput. Its tools serve cell research and biological discovery workflows, focusing on the physical interface between samples and existing imaging instrumentation.

1 investor

ImagoAI develops rapid food safety and quality testing solutions using hyperspectral imaging combined with AI for the food industry. The company targets on-site testing needs, particularly for detecting mycotoxins and other contaminants in food supply chains.

1 investor

Autonomous driving software company that develops AI-based, camera-centric self-driving technology for public transportation vehicles. The company partners with bus manufacturers and fleet operators to integrate autonomous solutions into buses and vans without requiring HD-maps or cloud infrastructure.

1 investor

Imec is an independent research and innovation center for nanoelectronics and digital technology, operating semiconductor pilot lines, cleanrooms, and labs used by industrial partners, startups, and universities. It conducts chip design and process R&D applied to fields such as health, automotive, agritech, and energy, working in an open innovation model with the global microchip value chain.

1 investor

Imiron develops formal verification and mathematical modelling technology for learning-enabled, mission-critical systems, applying formal methods to system design and verification. Its work targets domains such as autonomous driving and safety-critical automotive software.

1 investor

ImmPro provides top-down proteomics analytical services for biopharmaceutical development, using single-particle protein analysis to characterize proteins and proteoforms. Its offerings support gene therapy vector characterization, biomarker discovery, and disease-specific assays for areas such as neurodegeneration, oncology, and cardiometabolic disease.

1 investor

ImmuneSpecs uses immunopeptidomics (MAPPs) technology to identify peptides presented by MHC molecules, enabling precise mapping of T cell epitopes in biotherapeutics and validation of immunotherapy targets. The company serves biopharmaceutical organizations seeking advanced antigen presentation analysis.

1 investor

ImmunoBlue develops nanoimmunotherapies for cancer treatment by combining nanotechnology and immunotherapy. It operates in the biotech and therapeutics space.

1 investor

ImmunoScape is a Singapore-based biotechnology company developing high-throughput immune profiling and therapeutic T cell receptor discovery platforms for immunotherapy and cancer treatment. The company was spun off from Singapore's A*STAR research institute and serves the immunotherapy and oncology sectors.

1 investor

ImmunoVec develops programmable DNA-based in vivo medicines that use cell type- and cell state-specific synthetic promoters to control payload expression in targeted cells for treating cancer and autoimmune disease. Its expression cassettes can be incorporated into both viral and non-viral delivery vehicles such as lentivirus, AAV, lipid and polymeric nanoparticles, and exosomes.

1 investor

Impact Science Ventures (ISV) is an early-stage venture firm that identifies, invests in, and builds companies commercializing scientific breakthroughs in energy, materials, mining, chemicals, agriculture, and the built environment. It backs founders working on industrial innovation aimed at cost-efficient production, supply chain resilience, and climate goals.

1 investor

Implexis blends pharmaceutical expertise with automation to deliver impact in the life sciences industry.

1 investor

Impli develops implantable biotech devices that enable continuous monitoring of biological data, starting with hormone monitoring applications. The platform is designed to support personalized, preventive healthcare by tracking real-time shifts in stress, fertility, metabolism, and aging.

1 investor

Imprint Analytics provides analytical verification and authentication services to detect fraud and verify product origin and authenticity, primarily for food and consumer goods companies. The firm uses techniques like isotope analysis to ensure supply chain integrity and protect consumer trust.

1 investor

Impulse Biomed is a South African medical device company that develops affordable healthcare products, including the ZiBiPen reloadable adrenaline auto-injector and the Easy Squeezy inhaler attachment for asthma and allergy care. It focuses on making life-saving medical technologies accessible in under-resourced settings.

1 investor

IMS Group is a global private investment partnership that deploys capital across multiple divisions focused on specialist credit, venture building, and technology infrastructure. The group operates through four divisions—Capital Management, Digital Ventures, Labs, and Sports Capital—leveraging proprietary AI-driven platforms and a network of family offices and operators to invest in underserved opportunities across fintech, enterprise software, blockchain, and dual-use technologies.

1 investor

IMS Nanofabrication is a high-tech company specializing in electron-beam lithography, developing and manufacturing multi-electron-beam writers for semiconductor industry manufacturers. It operates in nanotechnology serving global semiconductor players.

1 investor

Imvizar builds augmented reality and immersive storytelling experiences that enhance physical locations for attractions, businesses, and brands. It combines interaction design and narrative content to improve the visitor experience at places and spaces.

1 investor

In A Blink develops edge routers and optical wireless communication solutions for transit vehicles, offering high-speed data transmission, cybersecurity, and edge computing capabilities for vehicle-to-infrastructure connectivity.

1 investor

INTHESMART is a medical device company with over 20 years of R&D experience, developing high-tech medical devices including endoscopic fluorescence imaging systems, AI fundus cameras, and smart robotic prosthetics. The company operates in collaboration with major hospitals and research institutes across South Korea, the United States, China, and Russia.

1 investor